CVS rallies on turnaround momentum and EPS growth, while CI is a defensive play with stable returns and a focused healthcare ...

This performance was primarily driven by its Cigna Healthcare segment ... You can also see if CI appears on our undervalued or overvalued stock lists. These tools provide a clearer picture ...

The subdued stock price reaction suggests that The Cigna Group's (NYSE:CI) strong earnings didn't offer any surprises. Our analysis suggests that investors might be missing some promising details.

On Friday, UBS analyst AJ Rice confirmed a Buy rating for Cigna (NYSE: CI) shares, maintaining the $390.00 price target.Rice provided insights following a recent investor event at the Evernorth ...

Following the earnings announcement, Cigna’s stock price rose by 2.4%, reflecting investor confidence in the company’s financial health and future prospects. The stock’s performance remains strong ...

You probably wouldn’t bet on a horse that usually finishes in the middle of the pack. But, in the stock market, sometimes ...

On Friday, UBS analyst AJ Rice confirmed a Buy rating for Cigna (NYSE: CI) shares, maintaining the $390.00 price target.Rice provided insights following a recent investor event at the Evernorth ...